The MRC randomised-controlled trial of interferon-alpha, interleukin-2 and 5-fluorouracil vs interferon-alpha alone in patients with advanced renal cell carcinoma (RE04): rationale and progress

Clin Oncol (R Coll Radiol). 2005 Aug;17(5):319-21. doi: 10.1016/j.clon.2005.03.007.
No abstract available

Publication types

  • Comparative Study
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / mortality
  • Humans
  • Interferon-alpha / administration & dosage
  • Interleukin-2 / administration & dosage
  • Kidney Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Time Factors
  • United Kingdom

Substances

  • Interferon-alpha
  • Interleukin-2